{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T22:13:14Z","timestamp":1720995194192},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T00:00:00Z","timestamp":1097539200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:p><jats:bold>Abstract: Background\/aims: <\/jats:bold> Halofuginone (HF) is an antifibrotic agent in rat models of liver fibrosis caused by repetitive intoxications. A beneficial effect of HF on a biliary type of liver fibrosis has not been proven yet.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> Bile duct\u2010obstructed rats were given HF from the moment of obstruction onwards and compared with no treatment. After 3 weeks, respectively, 6 weeks, aminopyrine breath test (ABT) and haemodynamic measurements including of portal pressure were carried out. Liver pieces were taken for Sirius red quantitative scoring, as well as for semiquantitative determinations of collagen type I and III RNA levels.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> ABT was significantly worse in HF\u2010treated rats as compared with no treatment (<jats:italic>P<\/jats:italic>=0.02). Haemodynamic data and collagen type I and III determinations were not significantly different between groups. Biliary fibrosis scores were significantly higher in HF\u2010treated rats as compared with no treatment (<jats:italic>P<\/jats:italic>=0.03). More Sirius red staining was associated with more proliferation of bile ductules.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> HF may worsen biliary fibrosis. This contrasts sharply with antifibrotic effects in other models of liver fibrosis. Distinctive cellular mechanisms in biliary fibrosis may explain this discrepancy. One should be cautious for chronic application of HF in man with cholestasis.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2004.0950.x","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T10:42:35Z","timestamp":1097577755000},"page":"502-509","source":"Crossref","is-referenced-by-count":9,"title":["Halofuginone can worsen liver fibrosis in bile duct obstructed rats"],"prefix":"10.1111","volume":"24","author":[{"given":"Marc","family":"Van de Casteele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Roskams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Van der Elst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos F.","family":"Van Pelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Fevery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-17558"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80186-9"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.21408"},{"key":"e_1_2_7_5_2","unstructured":"Excerpt from the European Veterinary Drug Registry. London http:\/\/www.eudra.org\/vetdocs\/vets\/Epar\/halocur\/halocur.htm"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4017(81)90004-2"},{"key":"e_1_2_7_7_2","first-page":"107","article-title":"Halofuginone","volume":"1156","author":"Granot I","year":"1993","journal-title":"an inhibitor of collagen type I synthesis"},{"key":"e_1_2_7_8_2","first-page":"15167","article-title":"Amelioration of radiation\u2010induced fibrosis","volume":"279","author":"Xavier S","year":"2004","journal-title":"inhibition of transforming growth factor-\u03b2 signaling by halofuginone"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00164-2"},{"key":"e_1_2_7_10_2","first-page":"257","volume-title":"Fat\u2010Storing Cells and Liver Fibrosis","author":"Desmet V J.","year":"1994"},{"key":"e_1_2_7_11_2","first-page":"259","article-title":"Ductular reaction and its diagnostic significance","volume":"15","author":"Roskams T","year":"1998","journal-title":"Semin Diagn Pathol"},{"key":"e_1_2_7_12_2","first-page":"693","article-title":"Experimental sclerosing cholangitis following intrabiliary injection of formol in the rat","volume":"118","author":"Houry S","year":"1992","journal-title":"Chirurgie"},{"key":"e_1_2_7_13_2","first-page":"358","article-title":"Secondary sclerosing cholangitis","volume":"20","author":"Pappalardo G","year":"1988","journal-title":"an experimental study"},{"key":"e_1_2_7_14_2","first-page":"163","article-title":"Role of formalin in the occurrence of sclerosing lesions of the bile ducts","volume":"121","author":"Grimaud J C","year":"1984","journal-title":"J Chir"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90850-X"},{"key":"e_1_2_7_16_2","first-page":"35","article-title":"Characterisation of portal hypertension models by microspheres in anaesthetised rats","volume":"90","author":"Van de Casteele M","year":"2001","journal-title":"a comparison of liver flow"},{"key":"e_1_2_7_17_2","first-page":"356","article-title":"The aminopyrine breath test as a measure of liver function","volume":"100","author":"Irving C S","year":"1982","journal-title":"J Lab Clin Med"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.3.440"},{"key":"e_1_2_7_19_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00570280","article-title":"Are picro\u2010dye reactions for collagens quantitative? Chemical and histochemical considerations","volume":"88","author":"Puchtler H","year":"1988","journal-title":"Histochemistry"},{"key":"e_1_2_7_20_2","first-page":"2","article-title":"Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide\u2010mediated NO breakdown","volume":"2","author":"Van de Casteele M","year":"2003","journal-title":"a comparison of two portal hypertensive rat models with healthy controls"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70370-2"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260316"},{"key":"e_1_2_7_23_2","first-page":"355","volume-title":"Pharmakotherapie bei Haus\u2010 und Nutztieren","author":"Steuber S","year":"1999"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(02)01009-7"},{"key":"e_1_2_7_25_2","first-page":"1261","article-title":"Vasoactive agents in intrahepatic portal hypertension and fibrogenesis","volume":"118","author":"Rockey D C.","year":"2000","journal-title":"implications for therapy"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00307-0"},{"key":"e_1_2_7_27_2","first-page":"1011","article-title":"Hepatic stellate cells as a target for TZD","volume":"36","author":"Tsukamoto H.","year":"2002","journal-title":"can we treat liver fibrosis and type II diabetes at the same time?"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2004.0950.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2004.0950.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:37:51Z","timestamp":1697297871000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2004.0950.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1478-3231.2004.0950.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2004.0950.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}